Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Item
http://www.wikidata.org/entity/Q34001579
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine productionPulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.Bacterial infectious disease control by vaccine development.Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.Tunable Lipidoid-Telodendrimer Hybrid Nanoparticles for Intracellular Protein Delivery in Brain Tumor Treatment.
P2860

Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Item
http://www.wikidata.org/entity/Q34001579
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@ast
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@en
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@nl
type
label
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@ast
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@en
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@nl
prefLabel
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@ast
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@en
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@nl
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
Expression and immunogenicity ...... i vaccine strain CVD 908-htrA.
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932